Mitogen-Activated Protein Kinase Kinase Kinase 8 (MAP3K8) (pSer290) Peptid
MAP3K8
Reaktivität: Human, Maus, Ratte, Rind (Kuh), Affe
Wirt: Synthetic
BP
-
- Target Alle MAP3K8 Produkte
- MAP3K8 (Mitogen-Activated Protein Kinase Kinase Kinase 8 (MAP3K8))
- Protein Region
- pSer290
- Spezies
- Human, Maus, Ratte, Rind (Kuh), Affe
-
Quelle
- Synthetic
- Applikation
- Blocking Peptide (BP)
- Produktmerkmale
- The peptide is used to block Anti-TPL2 (pT290) Antibody reactivity.
-
-
- Applikationshinweise
- Blocking Peptide to the diluted primary antibody in a molar ratio of 10:1 (peptide to antibody) and incubate the mixture at 4 °C for overnight or at room temperature for 2 hours.
- Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
- Format
- Lyophilized
- Lagerung
- -20 °C
- Informationen zur Lagerung
- Shipped at 4°C. Store at -20°C for one year.
- Haltbarkeit
- 12 months
-
- Target
- MAP3K8 (Mitogen-Activated Protein Kinase Kinase Kinase 8 (MAP3K8))
- Synonyme
- MAP3K8 Peptide, COT Peptide, EST Peptide, ESTF Peptide, MEKK8 Peptide, TPL2 Peptide, Tpl-2 Peptide, c-COT Peptide, Cot Peptide, Cot/Tpl2 Peptide, Est Peptide, Estf Peptide, Tpl2 Peptide, D17TPL2 Peptide, mitogen-activated protein kinase kinase kinase 8 Peptide, MAP3K8 Peptide, map3k8 Peptide, Map3k8 Peptide
- Hintergrund
- COT, ESTF, Mitogen-activated protein kinase kinase kinase 8, Cancer Osaka thyroid oncogene, Proto-oncogene c-Cot, Serine/threonine-protein kinase cot, Tumor progression locus 2, TPL-2
- Gen-ID
- 1326, 26410, 116596
- UniProt
- P41279, Q07174, Q63562
-
Sie sind hier:
